David A Fischer

1PUBLICATIONS
0CO-AUTHORS
Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 05, 2019
CSACI position statement: Newer generation H<sub>1</sub>-antihistamines are safer than first-generation H<sub>1</sub>-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria.

Michael N Fein, David A Fischer, Andrew W O'Keefe

Pageof 1

Frequent Collaborators